 Hello, my name is Apulina Ejikeng, Elite Biosciences Eastern and Central Africa. We want to tackle a critical question that of emerging and reemerging infectious disease which affect human, livestock, and wildlife. Outbreaks, such as the recent Ebola epidemic in West Africa, can cost thousands of human lives, billions of dollars, and can paralyze economies and health care systems with terrible consequences. The cost of controlling a disease such as Ebola rises exponentially once the disease spreads into humans from the animal reservoir. And yet our surveillance systems are focused on human patients. We propose to bring a novel sequence-based detection system developed by our collaborators at the Los Alamos National Laboratory to bear on the problem. We will use the 100 and change investment to establish this powerful technology in our networks of collaborating laboratories. This will provide a real-time picture of the pathogen activity in Africa to scientists and policymakers protecting both the communities in which disease emerge and the planet as a whole from periodic epidemics.